Author

Helen C. Perry

Observed names: H C Perry, H. C. PERRY, H. C. Perry, H. Perry, H.C. Perry, HELEN C. PERRY, Helen C Perry, Helen Perry

Observed institutions: Southern Research Institute, Henry M. Jackson Foundation, Merck & Co., Inc., Rahway, NJ, USA (United States), Beth Israel Deaconess Medical Center, Harvard University, United States Military Academy, Duke Medical Center

OpenAlex ID: A5000448246

Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein

1993 · Jeffrey B. Ulmer, John J. Donnelly, et al. · Science · 2,318

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

2002 · John W. Shiver, Tong-Ming Fu, et al. · Nature · 1,173

PDF

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

2003 · Danilo R. Casimiro, Ling Chen, et al. · Journal of Virology · 399

9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication.

1983 · A K Field, M E Davies, et al. · Proceedings of the National Academy of Sciences · 391

Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys

2004 · Jiang Fan, Xiaoping Liang, et al. · Vaccine · 315

Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination

1997 · Norman L. Letvin, David C. Montefiori, et al. · Proceedings of the National Academy of Sciences · 312

Attenuation of Simian Immunodeficiency Virus SIVmac239 Infection by Prophylactic Immunization with DNA and Recombinant Adenoviral Vaccine Vectors Expressing Gag

2005 · Danilo R. Casimiro, Fubao Wang, et al. · Journal of Virology · 271

Heterologous and Homologous Protection Against Influenza A by DNA Vaccination: Optimization of DNA Vectors

1993 · DONNA L. MONTGOMERY, JOHN W. SHIVER, et al. · DNA and Cell Biology · 262

Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys

2000 · Dan H. Barouch, Abie Craiu, et al. · Proceedings of the National Academy of Sciences · 200

Potent CD4+ T Cell Responses Elicited by a Bicistronic HIV-1 DNA Vaccine Expressing gp120 and GM-CSF

2002 · Dan H Barouch, Sampa Santra, et al. · The Journal of Immunology · 158

Augmentation and Suppression of Immune Responses to an HIV-1 DNA Vaccine by Plasmid Cytokine/Ig Administration

1998 · Dan H Barouch, Sampa Santra, et al. · The Journal of Immunology · 146

PDF

Effects of the nucleoside analog 2'-nor-2'-deoxyguanosine on human cytomegalovirus replication

1984 · M J Tocci, T J Livelli, et al. · Antimicrobial Agents and Chemotherapy · 107

Synthesis and antiherpetic activity of (.+-.)-9-[[(Z)-2-(hydroxymethyl)cyclopropyl]methyl]guanine and related compounds

1988 · Wallace T. Ashton, Laura Canning Meurer, et al. · Journal of Medicinal Chemistry · 96

Quantitative Adenovirus Neutralization Assays Based on the Secreted Alkaline Phosphatase Reporter Gene: Application in Epidemiologic Studies and in the Design of Adenovector Vaccines

2004 · Miguel Aste-Amézaga, Andrew J. Bett, et al. · Human Gene Therapy · 84

Synthesis and antiherpetic activity of (S)-, (R)-, and (.+-.)-9-[(2,3-dihydroxy-1-propoxy)methyl]guanine, linear isomers of 2'-nor-2'-deoxyguanosine

1985 · Wallace T. Ashton, Laura F. Canning, et al. · Journal of Medicinal Chemistry · 80

Oligopeptides inhibit the ribonucleotide reductase of herpes simplex virus by causing subunit separation

1988 · W. McClements, G. Yamanaka, et al. · Virology · 65

Cytotoxic T Lymphocyte and Helper T Cell Responses following HIV Polynucleotide Vaccination

1995 · JOHN W. SHIVER, HELEN C. PERRY, et al. · Annals of the New York Academy of Sciences · 59

Vaccine-Induced Immune Responses in Rodents and Nonhuman Primates by Use of a Humanized Human Immunodeficiency Virus Type 1 pol Gene

2002 · Danilo R. Casimiro, Aimin Tang, et al. · Journal of Virology · 46

Humoral and Cellular Immunities Elicited by HIV-1 DNA Vaccination

1996 · John W. Shiver, Mary-ellen Davies, et al. · Journal of Pharmaceutical Sciences · 45

A comparison of the antiviral agents 2′-nor-2′-deoxyguanosine and acyclovir: Uptake and phosphorylation in tissue culture and kinetics of in vitro inhibition of viral and cellular DNA polymerases by their respective triphosphates

1983 · John Germershausen, Richard Bostedor, et al. · Biochemical and Biophysical Research Communications · 44

Characterization of the herpes simplex virus origin binding protein interaction with OriS.

1991 · D.J. Hazuda, H.C. Perry, et al. · Journal of Biological Chemistry · 39

Cooperative interactions between replication origin-bound molecules of herpes simplex virus origin-binding protein are mediated via the amino terminus of the protein.

1992 · D.J. Hazuda, H.C. Perry, et al. · Journal of Biological Chemistry · 38

Vaccination of Mice and Nonhuman Primates using HIV-Gene-Containing DNA

2015 · Margaret A. Liu, Yasuhiro Yasutomi, et al. · Antibiotics and chemotherapy/Antibiotica et chemotherapia · 35

The DNA Binding Domain of Herpes Simplex Virus Type 1 Origin Binding Protein Is a Transdominant Inhibitor of Virus Replication

1993 · H.C. Perry, D.J. Hazuda, et al. · Virology · 30

Carba‐acyclonucleoside antiherpetic agents

1989 · John Hannah, Richard L. Tolman, et al. · Journal of Heterocyclic Chemistry · 27

Works count: 32

Citation count: 6,761

H-index: 25

I10-index: 26